PBIO News Alert Pressure Biosciences (PBIO) 0.3200 09/19/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 19, 2014 at 8:05 PM

Pressure Biosciences (PBIO) 0.3200 $PBIO

Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems
PR Newswire - Fri Sep 19, 8:55AM CDT
Biotech companies make announcements illustrating significant progress in medical technology, development of emerging drug systems and advanced Laboratory Instrumentation. Companies in focus today are: (OTC: PBIO), Benton, Dickinson and Company (NYSE: BDX), Thermo Fisher Scientific Inc. (NYSE: TMO), Regado Biosciences Inc. (NASDAQ: RGDO), Sangamo Biosciences Inc. (NASDAQ: SGMO) and Hologic Inc. (NASDAQ: HOLX)

Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System
PR Newswire - Fri Sep 19, 7:31AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"

today announced it has received and approved all parts required to build nine high throughput Barozyme HT48 instruments and has begun to manufacture the new PCT-based instrument system. The Company believes the first instrument will be ready for shipment by mid-October and that additional Barozyme instruments will be built and released at a rate of about one per week thereafter.

Steady Growth and Cutting-Edge Technologies Are Trademarks of Pressure BioSciences, Inc. (PBIO)
ACCESSWIRE - Mon Sep 15, 7:45AM CDT
Boca Raton, FL / ACCESSWIRE / September 15, 2014 / Thanks to a combination of market ingenuity and a strong scientific core, life science stalwart Pressure BioSciences (OTCQB

BIO) continues to enjoy a resurgence of relevance as a veteran company. PBIO's patented "pressure cycling technology, "or PCT", is an up-and-coming, exciting, critically acclaimed resource for scientific sample preparation by its unique ability to offer unparalleled control of the actions of molecular cell and tissue samples through an intense pressure system. This process is used in applications as diverse as forensics, bio-marker discovery, and vaccine development.

Pressure BioSciences, Inc. to Present at Rodman & Renshaw and SeeThruEquity NY Investment Conferences
PR Newswire - Wed Sep 10, 9:56AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"

today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the Rodman and Renshaw ("Rodman"

and SeeThruEquity ("STE"

Investment Conferences this week in New York City. Mr. Schumacher's presentation at Rodman is scheduled for Wednesday, September 10 at 12:05pm in the Palace Hotel. Mr. Schumacher's presentation at STE is scheduled for Thursday, September 11 at 9:00am at the Convene Times Square.

Pressure BioSciences Inc. ("PBI"

(OTCQB: PBIO) Exclusive Interview for Interlinked's Investment News Channel, InterlinkedTV at FSXinterlinked Investment Conference
PRWeb - Thu Aug 28, 5:02AM CDT
Pressure BioSciences Inc., ("PBI"

(OTCQB: PBIO) was one of the presenting companies at the recent FSXinterlinked Investment Conference held at the Four Seasons Hotel in Westlake Village, California.

Pressure BioSciences, Inc. ("PBI"

(OTCQB: PBIO) to Discuss Second Quarter 2014 Financial Results and Provide a Business Update
PRWeb - Wed Aug 13, 6:05PM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"

today announced that the Company will host a teleconference to discuss its Second Quarter 2014 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay by telephone or on the Company's website.

Pressure BioSciences Inc. to Host Second Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, August 14, 2014
ACCESSWIRE - Wed Aug 13, 3:06PM CDT
SOUTH EASTON, MA / ACCESSWIRE / August 13, 2014 / Pressure BioSciences Inc. (OTCQB: PBIO) will host a conference call and live webcast to discuss the results of the second quarter 2014, to be held Thursday, August 14, 2014 at 4:30 PM Eastern Time.

Pressure BioSciences, Inc. to Discuss Second Quarter 2014 Financial Results and Provide a Business Update
PR Newswire - Wed Aug 13, 7:23AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"

and Parabase Genomics ("Parabase"

, (together "the companies"

, today announced they have entered into a strategic research and development agreement (the "collaboration"

. Under the terms of the collaboration, PBI will develop a front-end, sample preparation method for Parabase's enhanced neonatal molecular diagnostics and newborn confirmatory testing process. The sample preparation method will be based on PBI's patented and enabling Pressure Cycling Technology ("PCT"

platform.

Pressure BioSciences, Inc. (OTCQB: PBIO) to Present at the FSXinterlinked Investment Conference
PRWeb - Tue Jul 15, 6:08AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"

today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the FSXinterlinked Investment Conference being held from July 30th to August 2nd, 2014 at the Four Seasons, Westlake Village, CA.

Pressure BioSciences Engages IssuWorks in Strategic Advisory Role
PR Newswire - Thu Jun 26, 8:53AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"

today announced the engagement of IssuWorks to provide strategic advisory services to the Company's board of directors and management team. IssuWorks is the first conflict-free, company-aligned investment bank using technology and services to dramatically improve investor targeting, securities marketing, and distribution in public and private markets. Pressure BioSciences has retained IssuWorks and their management team to review strategic and financing alternatives, including the possible spin-off of vertical market applications into new, stand alone businesses.

Launch of Novel, High Throughput PCT-based Barozyme HT48 System "Very Successful" Says Pressure BioSciences
PR Newswire - Mon Jun 23, 7:16AM CDT
On June 12, 2014, Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"

announced the planned launch of their much anticipated, high throughput pressure cycling technology ("PCT"

-based system at the 62nd conference of the American Society for Mass Spectrometry ("ASMS"

. The ASMS Conference was held June 15-19, 2014 in Baltimore, MD.

Transformative Impact and Adoption of Pressure BioSciences' PCT Platform Prominently Highlighted Throughout Week at Major Scientific Conference
PR Newswire - Thu Jun 19, 10:46AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"

today announced that scientists from six separate research groups presented data at the 62nd Annual Conference of the American Society for Mass Spectrometry ("ASMS"

being held from June 15-19, 2014 in Baltimore, MD. Study results indicated that utilizing the Company's patented pressure cycling technology ("PCT"

platform in the preparation of samples for analysis resulted in critically enabling quality and/or improved time or cost efficiency of test results. These studies were conducted by scientists from ETH Zurich and the University of Zurich ("ETH Zurich"

; Laboratory Corporation of America ("Lab Corp"

; the Food and Drug Administration ("FDA"

; the University of Minnesota ("UMN"

, Mayo Clinic, and the Karolinska Instituet; Northeastern University ("NEU"

; and the Baltimore VA Medical Center ("BVAMC"

, SAIC-Frederick, National Cancer Institute, and the Veteran's Health Administration.

Pressure BioSciences to Launch Its Much Anticipated High Throughput PCT-based Instrument System (the Barozyme HT48) at the Upcoming ASMS Annual Conference
PR Newswire - Thu Jun 12, 11:43AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"

today announced it will launch its high throughput, PCT-based Barozyme HT48 instrument system for the enhanced preparation of proteins for mass spectrometry analysis at the upcoming American Society for Mass Spectrometry ("ASMS"

Annual Conference on Mass Spectrometry and Allied Topics. The ASMS Conference is being held June 15-19, 2014 in Baltimore, Maryland.

Pressure BioSciences, Inc. Reports Strong Fourth Quarter and Fiscal Year 2013 Financial Results
PR Newswire - Tue Apr 01, 9:42AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"

today announced financial results for the three-month period and fiscal year ended December 31, 2013 and provided a business update.

Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2013 Financial Results and Provide a Business Update
PR Newswire - Mon Mar 31, 8:37AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"

today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2013 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay on the Company's website. The teleconference information is provided below:

Pressure BioSciences Inc. Exclusive Interview for the Interlinked Investment News Channel on InterlinkedTV
PRWeb - Fri Mar 21, 3:37PM CDT
Pressure BioSciences Inc. was one of the presenting companies interviewed at the recent FSXinterlinked Investment Conference, held at the Ritz Carlton in Dallas, Texas.

Pressure BioSciences Announces the Release and Initial Sale of the Barocycler HUB880, a "First-in-Kind" Ultra High Pressure Bench-top Instrument System
PR Newswire - Wed Mar 19, 9:23AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"

today announced the commercial release of the Barocycler HUB880, the newest addition to the Company's growing line of high-pressure instrument systems. The Company also announced the sale (and shipment) of its first HUB880 system to Dr. Wayne Hubbell of the University of California Los Angeles (UCLA). PBI plans to showcase the HUB880 at the upcoming U.S. Human Proteome Organization's 10th Annual Conference to be held at the Westin-Seattle (WA), April 6-9, 2014.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

NatGold Pulling NATG From MEXC Amid Security Concerns

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Boston STEM Expo Sparks Young Minds in Engineering

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Historic Records Set at 2026 CNO Monumental Marathon

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Evaluating GLP-1 Telehealth? Key Questions to Consider

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Johnson & Johnson Unveils Promising PsA Treatment Data

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Intelligent Communication Forum Eyes Global Ecosystem Shift

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Quantum Space Joins $185M NASA Lunar Transport Deal

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Off-Broadway Play 'DUST' Raises Autism Support Funds

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...